[HTML][HTML] Nutraceuticals: a promising therapeutic approach in ophthalmology

CR Castro-Castaneda, F Altamirano-Lamarque… - Nutrients, 2022 - mdpi.com
Oxidative stress represents one of the main factors driving the pathophysiology of multiple
ophthalmic conditions including presbyopia, cataracts, dry eye disease (DED), glaucoma …

[HTML][HTML] Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury

WH Moos, DV Faller, IP Glavas, DN Harpp… - Biochemical …, 2022 - Elsevier
Pathological deterioration of mitochondrial function is increasingly linked with multiple
degenerative illnesses as a mediator of a wide range of neurologic and age-related chronic …

[HTML][HTML] BCLA CLEAR Presbyopia: Epidemiology and impact

M Markoulli, TR Fricke, A Arvind, KD Frick… - Contact Lens and …, 2024 - Elsevier
The global all-ages prevalence of epidemiologically-measured 'functional'presbyopia was
estimated at 24.9% in 2015, affecting 1.8 billion people. This prevalence was projected to …

[HTML][HTML] BCLA CLEAR Presbyopia: Evaluation and diagnosis

JS Wolffsohn, D Berkow, KY Chan… - Contact Lens and …, 2024 - Elsevier
It is important to be able to measure the range of clear focus in clinical practice to advise on
presbyopia correction techniques and to optimise the correction power. Both subjective and …

[HTML][HTML] BCLA CLEAR Presbyopia: Management with contact lenses and spectacles

PB Morgan, N Efron, E Papas, M Barnett… - Contact Lens and …, 2024 - Elsevier
This paper seeks to outline the history, market situation, clinical management and product
performance related to the correction of presbyopia with both contact lenses and spectacles …

Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia

S Panja, RB Nahomi, J Rankenberg, CR Michel… - Aging …, 2023 - Wiley Online Library
Aging proteins in the lens become increasingly aggregated and insoluble, contributing to
presbyopia. In this study, we investigated the ability of aggrelyte‐2 (N, S‐diacetyl‐L‐cysteine …

[HTML][HTML] Review of presbyopia treatment with corneal inlays and new developments

M Moshirfar, MK Henrie, CJ Payne, BK Ply… - Clinical …, 2022 - ncbi.nlm.nih.gov
Presbyopia may represent the largest segment of refractive errors that is without an
established and effective refractive surgery treatment. Corneal Inlays are materials (synthetic …

[HTML][HTML] Pharmacological treatment in presbyopia

A Grzybowski, V Ruamviboonsuk - Journal of clinical medicine, 2022 - mdpi.com
Pharmacological treatment of presbyopia may be an alternative for those who want a
spectacle-free scenario and an easy-to-use method with lower risk of irreversible ocular …

[HTML][HTML] Applications of SMILE-extracted lenticules in ophthalmology

H Aghamollaei, H Hashemi, M Fallahtafti… - International Journal …, 2024 - ncbi.nlm.nih.gov
AIM To review recent innovations, challenges, and applications of small incision lenticule
extraction (SMILE) extracted lenticule for treating ocular disorders. METHODS A literature …

Pilocarpine 1.25% and the changing landscape of presbyopia treatment

BB Meghpara, JK Lee, CJ Rapuano… - Current opinion in …, 2022 - journals.lww.com
Vuity is the first treatment designed and FDA approved to treat the growing presbyopia
market. Phase 3 clinical trials demonstrated its ability to improve near vision without …